Is a complete LON/0R1B research report available?

No complete published report is available for lon/0R1B (LON/0R1B) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

LON/0R1B (LON/0R1B)

London Stock Exchange: LON/0R1B · USD

$203

+1.17 (+0.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LON/0R1B analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	22.9B
Revenue (ttm)	7.5B
Net income (ttm)	1B
EPS (ttm)	$7.04
P/E (trailing)	22.0x
P/E (forward)	16.7x
Volume	200
Beta	0.16

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.5B
Net income (ttm): 1B
EPS (ttm): $7.04
P/E (trailing): 22.0x
P/E (forward): 16.7x
Market cap: 22.9B

All LON/0R1B indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	7,500
Employees Change	-105%
Employees Change Percent	-1.38
Enterprise value	$24.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US09062X1037
Last refreshed	2026-07-29
Market cap	$22.9B
Price	$203
Price currency	USD
Rev Per Employee	1,003,419.03x
Sector	Healthcare
Sector PE	20.93
Sector PE Fwd	14.57
Sic	2836
Symbol	lon/0R1B
Website	https://www.biogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.54%
EV Earnings	23.33x
EV/EBIT	11.78x
EV/EBITDA	8.81x
EV/FCF	13.21x
EV/Sales	3.25x
FCF yield	8.02%
Forward P/E	16.71x
P/B ratio	1.62x
P/E ratio	22.02x
P/S ratio	3.04x
PE Ratio10 Y	16.99x
PE Ratio3 Y	19.86x
PE Ratio5 Y	19.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.56%
EBITDA Margin	35.62%
FCF margin	24.54%
Gross margin	78.72%
Gross Profit	$5.9B
Gross Profit Growth	2.83%
Gross Profit Growth Q	0.78%
Gross Profit Growth3 Y	-0.4%
Gross Profit Growth5 Y	-6.2%
Net Income	$1B
Net Income Growth	-7.26%
Net Income Growth Q	32.85%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-24.05%
Net Income Growth5 Y	-14.55%
Pretax Margin	16.33%
Profit Margin	13.81%
Profit Per Employee	$138,526
Profitable Quarters	$1
Profitable Years	14
ROA	5.95
Roa5y	6.68
ROCE	10.34
ROE	7.7
Roe5y	13.26
ROIC	11.02
Roic5y	13.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	54.08%
Cagr3y	-8.54%
Cagr5y	-9.48%
EPS Growth	-8.1
EPS Growth Q	31.1
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-24.42
EPS Growth5 Y	-13.58
FCF Growth	-0.57%
FCF Growth Q	167.46%
FCF Growth3 Y	19.25%
FCF Growth5 Y	-5.2%
OCF Growth	0.36%
OCF Growth Q	148.94%
OCF Growth10 Y	-4.25%
OCF Growth3 Y	15.58%
OCF Growth5 Y	-6.01%
Revenue Growth	1.23x
Revenue Growth Q	1.93x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.55x
Revenue Growth5 Y	-4.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.35
Assets	$22.3B
Cash	$3.2B
Current Assets	$6.9B
Current Liabilities	$2.3B
Debt	$5B
Debt EBITDA	$1.79
Debt Equity	$0.35
Debt FCF	$2.71
Equity	$14.1B
Interest Coverage	9.95
Liabilities	$8.2B
Long Term Assets	$15.4B
Long Term Liabilities	$5.9B
Net Cash	$-1.4B
Net Cash By Market Cap	$-6
Net Debt EBITDA	$0.51
Net Debt Equity	$0.1
Net Debt FCF	$0.75
Tangible Book Value	$2.4B
Tangible Book Value Per Share	$15.95
WACC	4.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	1
Net Working Capital	$1.4B
Quick ratio	2.03
Working Capital	$4.7B
Working Capital Turnover	$1.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	54.03%
200-day SMA	182
3Y total return	-23.49%
50-day SMA	199.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-39.23%
All Time High	466.3
All Time High Change	-56.59%
All Time High Date	2021-06-07
All Time Low	110.2
All Time Low Change	83.68%
All Time Low Date	2025-04-09
ATR	10
Beta	0.16
Ch YTD	14.4
High	204.5
High52	225
High52 Date	2026-05-14
High52ch	-9.87%
Low	200
Low52	124.7
Low52 Date	2025-08-01
Low52ch	62.58%
Ma50ch	1.26%
Price vs 200-day SMA	11.23%
RSI	49.25
RSI Monthly	55.48
RSI Weekly	58.9
Sharpe ratio	1.51x
Sortino ratio	2.62
Total Return	-1.01%
Tr YTD	14.4
Tr1m	-4.96%
Tr1w	-0.31%
Tr3m	10.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$2.1B
Operating Income Growth	3.02
Operating Income Growth Q	-16.14
Operating Income Growth3 Y	-1.83
Operating Income Growth5 Y	-6.09
Operating margin	27.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147,175,075%
Net Borrowing	-223,436,251.6
Shares Insiders	0.21%
Shares Institutions	97.31%
Shares Qo Q	1.16%
Shares Yo Y	1.01%
Short Ratio	4.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.6B
Adjusted OCF	1,739,529,585
Average Volume	1,282.6x
Bv Per Share	95.7
CAPEX	$-127.2M
Ch1m	-4.96
Ch1w	-0.31
Ch1y	54.03
Ch3m	10.01
Ch3y	-23.49
Ch5y	-39.23
Ch6m	17.22
Change	0.58%
Change From Open	1.39
Close	201.6
Days Gap	-0.8
Depreciation Amortization	602,879,020.4
Dollar Volume	40,558
Earnings Date	2026-07-29
EBIT	$2.1B
EBITDA	$2.7B
EPS	$7.04
F Score	6
FCF	$1.8B
FCF EV Yield	7.57x
Financing CF	-244,382,324
Fiscal Year End	December
Founded	1,978
Goodwill	4,883,162,026.8
Graham Number	161.05959
Graham Upside	-20.58
Income Tax	$190.2M
Investing CF	-1,161,175,757
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	$46.04
Lynch Upside	-77.3
Ma150	188.9
Ma150ch	7.18%
Ma20	205.1
Ma20ch	-1.32%
Net CF	594,030,042
Next Earnings Date	2026-07-29
Open	200
P FCF Ratio	12.47
P FCF Ratio SBC	14.19
P OCF Ratio	11.66
P OCF Ratio SBC	13.15
Position In Range	61.37
Ppne	2,460,282,228.8
Price Date	2026-07-28
Price EBITDA	$8.54
Ptbv Ratio	9.72
Relative Volume	0.16x
Revenue	7,525,642,707x
SBC By Revenue	2.96x
Share Based Comp	222,496,209
Tax By Revenue	2.53x
Tax Rate	15.47%
Tr6m	17.22%
Volume	200
Z Score	3.12

LON/0R1B (LON/0R1B)

Coverage state: Market snapshot only — no published research

Generate the first LON/0R1B analysis

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R1B

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R1B indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LON/0R1B

Frequently asked questions